A Study of IMC-A12 Every 2 Weeks in Patients With Tumors Who No Longer Respond to Treatment or No Treatment is Available

Name: A Study of IMC-A12 Every 2 Weeks in Patients With Tumors Who No Longer Respond to Treatment or No Treatment is Available
Published: 2006
License: Public Domain

Eli Lilly and Company · 2006

ClinicalTrials.gov · Datasets · License: Public Domain · 2006

Open Source ↗

antibodies monoclonal

advanced solid tumors, tumors, antibodies, monoclonal, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Study of IMC-A12 Every 2 Weeks in Patients With Tumors Who No Longer Respond to Treatment or No Treatment is Available

Related documents